ArticleThe Prostate2022

Association between duration of gonadotrophin-releasing hormone agonist use and cardiovascular risks: A population-based competing-risk analysis.

Jeffrey S K Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.